FDAnews
www.fdanews.com/articles/156958-roche-halts-investigation-of-aleglitazar-following-regular-safety-review-of-phase-iii-trial

Roche Halts Investigation of Aleglitazar Following Regular Safety Review of Phase III Trial

July 10, 2013
Roche has discontinued its trial of aleglitazar, called AleCardio, due to safety problems and lack of efficacy.
Roche